Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BLINK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ALT-Q5
|
|||||
| Synonyms |
ALT-Q5 ADC; ALT Q5 ADC; Q5-drug conjugate (Alteogen); ALT Q5; ALT-05; ALTQ5
Click to Show/Hide
|
|||||
| Organization |
Alteogen, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Epithelial ovarian cancer [ICD11:2B5D]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Folate receptor alpha (FOLR1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
NexMab ADC technology.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.